Efficient transduction of human hematopoietic cells with the human multidrug resistance gene 1 via SV40 pseudovirions

Human Gene Therapy
Deborah RundA Oppenheim

Abstract

Transduction of MDR1 may be of use in chemoprotection of normal bone marrow (BM) cells during treatment of malignancies, or as a selectable marker for the transfer of other genes into the BM, a critical target for the cure of many diseases. To that aim, the human multidrug resistance gene MDR1 was cloned into an SV40 pseudoviral vector containing the SV40 origin of replication (ori) and encapsidation signal (ses), and the plasmid was encapsidated in COS cells as SV40/MDR1 pseudovirions. Expression of the human MDR1 gene was demonstrated in murine MEL cells infected with SV40/MDR1 pseudovirions, using a monoclonal antibody (MPK16) specific for the human 170-kD P-glycoprotein. Functional P-glycoprotein was demonstrated by resistance to colchicine in NIH-3T3 cells infected with SV40/MDR1 pseudovirions. Activity of P-glycoprotein was assayed by rhodamine-123 dye exclusion and fluorescence-activated cell sorter analysis (FACS) in various cell types including hematopoietic cells. Highly efficient gene transfer and expression was demonstrated in all murine and human cell types tested, including primary human BM cells. Using multiplicities of infection (moi) of 1-2, over 95% of cells were found to become MDR1+. The percent of MDR1+ cel...Continue Reading

References

Sep 1, 1992·Journal of Virology·A OppenheimS Ottolenghi
Oct 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·S PoddaA Bank
Dec 1, 1990·European Journal of Obstetrics, Gynecology, and Reproductive Biology·A BerrebiG Pontonnier
Oct 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·H Hamada, T Tsuruo
Apr 15, 1989·Gene·A Oppenheim, A Peleg
Jan 1, 1987·Annals of the New York Academy of Sciences·A OppenheimE A Rachmilewitz
Nov 1, 1985·Molecular and Cellular Biology·R D Gerard, Y Gluzman
Sep 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·A OppenheimE A Rachmilewitz
Aug 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·E S KawasakiF P McCormick
May 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·K UedaI Pastan
Jan 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·J R HartmanG C Fareed
Apr 15, 1994·Cancer·D DrimanJ Squire
Jan 1, 1995·Annual Review of Genetics·M M GottesmanI Pastan

❮ Previous
Next ❯

Citations

Mar 29, 2000·Critical Reviews in Oncology/hematology·D Rund, E Rachmilewitz
Jan 29, 2002·Human Gene Therapy·Chava Kimchi-SarfatyMichael M Gottesman
Mar 5, 2003·Human Gene Therapy·Chava Kimchi-SarfatyMichael M Gottesman
Jun 1, 2004·DNA and Cell Biology·Maria Vera, Puri Fortes
Jan 25, 2000·Journal of Hematotherapy & Stem Cell Research·N Dalyot-HermanA Oppenheim
Oct 21, 1999·Journal of Cellular Physiology·D S Strayer
Jun 1, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·David S StrayerJohn A Zaia
Sep 29, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Maria VeraPuri Fortes
Jul 18, 2003·The Journal of General Virology·Editte GharakhanianLuz Mayorca
Jun 3, 2010·Cold Spring Harbor Protocols·David S StrayerCarmen N Nichols

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.